It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Rany Aburashed, DO
|
Consultant/Advisor: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme
Grant/Research Support: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme |
| Rachel Dorsey-Campbell, BPharm, MRPharmS, MFRPSII, NMP
|
Consultant/Advisor: Biogen; Merck & Co.; Novartis AG; Roche; Sanofi Genzyme
Speaker’s Bureau: Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme |
| Prof. Gavin Giovannoni
|
Consultant/Advisor: AbbVie, Inc.; Actelion; ASLAN Pharmaceuticals; Atara Biotherapeutics, Inc.; Biogen; Bristol Myers Squibb Company; Celgene Corporation; EMD Serono, Inc.; Genentech, Inc.; GlaxoSmithKline plc.; GW Pharmaceuticals plc; Janssen Pharmaceuticals Inc.; Japan Tobacco; LIFNano Rx Limited; Merck & Co.; Merck KGaA; Novartis AG; Roche; Sanofi Genzyme; Teva Pharmaceuticals
Speaker’s Bureau: AbbVie, Inc.; Actelion; Biogen; Bristol Myers Squibb Company; Celgene Corporation; EMD Serono, Inc.; Genentech, Inc.; Janssen Pharmaceuticals Inc.; Jazz Pharmaceuticals, Inc.; Merck KGaA; Novartis AG; Roche; Sanofi Genzyme |
| Dr. Benjamin Greenberg
|
Consultant/Advisor: Alexion; Cycle Pharma; EMD Serono; Genentech/Roche; Genzyme; Horizon Therapeutics; Immunovant; IQVIA; Novartis; Sandoz; Signant
Grant/Research Support: Anokion; Clene Nanomedicine; NIH; Regeneron |
| Jaime Imitola, MD | Consultant/Advisor: Biogen; Novartis AG
Grant/Research Support: Biogen |
| Stephen Krieger, MD | Consultant/Advisor: Biogen; EMD Serono, Inc.; Genentech, Inc.; Mallinckrodt Pharmaceuticals; MedDay Pharmaceuticals; Novartis AG; Sanofi Genzyme; Teva Pharmaceuticals; TG Therapeutics
Grant/Research Support: Biogen; Novartis AG Speaker’s Bureau: Biogen; EMD Serono, Inc.; Genentech, Inc.; Novartis AG |
| Sarah Levy, PhD | Nothing to Disclose |
| Jacqueline Nicholas, MD, MPH | Consultant/Advisor: Alexion Pharmaceuticals; EMD Serono, Inc.; Genentech, Inc.; Greenwich Biosciences, Inc.; Novartis AG; TG Therapeutics
Grant/Research Support: Biogen Speaker’s Bureau: Alexion Pharmaceuticals; EMD Serono, Inc.; Genentech, Inc. |
| Gabriel Pardo, MD, FAAN | Consultant/Advisor: EMD Serono; TG Therapeutics; Horizon Therapeutics; Novartis Pharmaceuticals; Greenwich Pharmaceuticals; Bristol Myers Squibb/Celgene
Speaker’s Bureau: Biogen Idec; EMD Serono; Roche/Genentech; Sanofi Genzyme; Novartis Pharmaceuticals; Janssen; Celgene; Prime Education Stock: Progentec Diagnostics Grant/Research Support: Biogen Idec; Roche/Genentech; Sanofi Genzyme; Novartis Pharmaceuticals; EMD Serono; Abbvie; Bristol Myers Squibb/Celgene |
| Barry Singer, MD
|
Consultant/Advisor: AbbVie, Inc.; Alexion Pharmaceuticals; Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Janssen Pharmaceuticals Inc.; Genentech, Inc.; Greenwich Biosciences, Inc.; Novartis AG; Roche; Sanofi Genzyme; TG Therapeutics
Grant/Research Support: AbbVie, Inc.; Alkermes; Biogen; Greenwich Biosciences, Inc.; Medimmune, LLC; Novartis AG; Roche; Sanofi Genzyme |
| Mitzi Joi Williams, MD
|
Consultant/Advisor: AbbVie, Inc.; Biogen; Bristol Myers Squibb Company; EMD Serono, Inc.; Genentech, Inc.; Novartis AG; Sanofi Genzyme
Grant/Research Support: EMD Serono, Inc.; Genentech, Inc.; Novartis AG |
| Mary Alissa Willis, MD
|
Consultant/Advisor: Genentech, Inc.; Greenwich Biosciences, Inc.
Grant/Research Support: Alexion Pharmaceuticals; Biogen; Bristol Myers Squibb Company; Genentech, Inc. |
All relevant financial relationships with ineligible companies for this educational content have been mitigated.
